vs

Side-by-side financial comparison of New Fortress Energy Inc. (NFE) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

New Fortress Energy Inc. is the larger business by last-quarter revenue ($326.2M vs $164.7M, roughly 2.0× PTC THERAPEUTICS, INC.). PTC THERAPEUTICS, INC. runs the higher net margin — -82.0% vs -259.7%, a 177.7% gap on every dollar of revenue. On growth, New Fortress Energy Inc. posted the faster year-over-year revenue change (-7.0% vs -22.7%). PTC THERAPEUTICS, INC. produced more free cash flow last quarter ($-36.6M vs $-134.8M). Over the past eight quarters, PTC THERAPEUTICS, INC.'s revenue compounded faster (-11.5% CAGR vs -26.8%).

New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

NFE vs PTCT — Head-to-Head

Bigger by revenue
NFE
NFE
2.0× larger
NFE
$326.2M
$164.7M
PTCT
Growing faster (revenue YoY)
NFE
NFE
+15.8% gap
NFE
-7.0%
-22.7%
PTCT
Higher net margin
PTCT
PTCT
177.7% more per $
PTCT
-82.0%
-259.7%
NFE
More free cash flow
PTCT
PTCT
$98.1M more FCF
PTCT
$-36.6M
$-134.8M
NFE
Faster 2-yr revenue CAGR
PTCT
PTCT
Annualised
PTCT
-11.5%
-26.8%
NFE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NFE
NFE
PTCT
PTCT
Revenue
$326.2M
$164.7M
Net Profit
$-847.1M
$-135.0M
Gross Margin
35.5%
Operating Margin
-193.0%
-43.3%
Net Margin
-259.7%
-82.0%
Revenue YoY
-7.0%
-22.7%
Net Profit YoY
-277.4%
-104.8%
EPS (diluted)
$-3.03
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NFE
NFE
PTCT
PTCT
Q4 25
$326.2M
$164.7M
Q3 25
$240.3M
$211.0M
Q2 25
$228.1M
$178.9M
Q1 25
$384.9M
$1.2B
Q4 24
$350.7M
$213.2M
Q3 24
$446.0M
$196.8M
Q2 24
$291.2M
$186.7M
Q1 24
$609.5M
$210.1M
Net Profit
NFE
NFE
PTCT
PTCT
Q4 25
$-847.1M
$-135.0M
Q3 25
$-263.0M
$15.9M
Q2 25
$-546.5M
$-64.8M
Q1 25
$-175.4M
$866.6M
Q4 24
$-224.4M
$-65.9M
Q3 24
$9.3M
$-106.7M
Q2 24
$-88.9M
$-99.2M
Q1 24
$54.1M
$-91.6M
Gross Margin
NFE
NFE
PTCT
PTCT
Q4 25
35.5%
Q3 25
18.1%
Q2 25
8.4%
Q1 25
21.4%
Q4 24
17.6%
Q3 24
27.1%
Q2 24
23.8%
Q1 24
62.4%
Operating Margin
NFE
NFE
PTCT
PTCT
Q4 25
-193.0%
-43.3%
Q3 25
-37.4%
1.4%
Q2 25
-170.3%
-19.5%
Q1 25
-3.3%
82.5%
Q4 24
65.0%
-76.2%
Q3 24
17.8%
-27.7%
Q2 24
12.3%
-21.5%
Q1 24
30.4%
-21.6%
Net Margin
NFE
NFE
PTCT
PTCT
Q4 25
-259.7%
-82.0%
Q3 25
-109.4%
7.5%
Q2 25
-239.6%
-36.3%
Q1 25
-45.6%
73.7%
Q4 24
-64.0%
-30.9%
Q3 24
2.1%
-54.2%
Q2 24
-30.5%
-53.1%
Q1 24
8.9%
-43.6%
EPS (diluted)
NFE
NFE
PTCT
PTCT
Q4 25
$-3.03
$-1.63
Q3 25
$-0.96
$0.20
Q2 25
$-1.99
$-0.83
Q1 25
$-0.65
$10.04
Q4 24
$-1.10
$-0.85
Q3 24
$0.03
$-1.39
Q2 24
$-0.42
$-1.29
Q1 24
$0.23
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NFE
NFE
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$226.5M
$1.9B
Total DebtLower is stronger
$8.2B
Stockholders' EquityBook value
$182.6M
$-205.3M
Total Assets
$10.6B
$2.9B
Debt / EquityLower = less leverage
44.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NFE
NFE
PTCT
PTCT
Q4 25
$226.5M
$1.9B
Q3 25
$145.2M
$1.7B
Q2 25
$551.1M
$2.0B
Q1 25
$447.9M
$2.0B
Q4 24
$492.9M
$1.1B
Q3 24
$90.8M
$1.0B
Q2 24
$133.0M
$1.1B
Q1 24
$143.5M
$884.8M
Total Debt
NFE
NFE
PTCT
PTCT
Q4 25
$8.2B
Q3 25
Q2 25
Q1 25
Q4 24
$8.9B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NFE
NFE
PTCT
PTCT
Q4 25
$182.6M
$-205.3M
Q3 25
$1.1B
$-155.8M
Q2 25
$1.3B
$-206.5M
Q1 25
$1.8B
$-185.8M
Q4 24
$1.9B
$-1.1B
Q3 24
$1.6B
$-1.1B
Q2 24
$1.6B
$-980.2M
Q1 24
$1.7B
$-893.9M
Total Assets
NFE
NFE
PTCT
PTCT
Q4 25
$10.6B
$2.9B
Q3 25
$12.0B
$2.6B
Q2 25
$12.0B
$2.6B
Q1 25
$13.1B
$2.7B
Q4 24
$12.9B
$1.7B
Q3 24
$12.0B
$1.8B
Q2 24
$11.4B
$1.9B
Q1 24
$10.9B
$1.8B
Debt / Equity
NFE
NFE
PTCT
PTCT
Q4 25
44.78×
Q3 25
Q2 25
Q1 25
Q4 24
4.74×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NFE
NFE
PTCT
PTCT
Operating Cash FlowLast quarter
$-76.2M
$-34.3M
Free Cash FlowOCF − Capex
$-134.8M
$-36.6M
FCF MarginFCF / Revenue
-41.3%
-22.3%
Capex IntensityCapex / Revenue
18.0%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.4B
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NFE
NFE
PTCT
PTCT
Q4 25
$-76.2M
$-34.3M
Q3 25
$-171.0M
$-66.3M
Q2 25
$-329.0M
$-58.3M
Q1 25
$-7.2M
$870.1M
Q4 24
$445.3M
$-30.0M
Q3 24
$-20.0M
$-77.0M
Q2 24
$113.9M
$-71.5M
Q1 24
$63.0M
$70.8M
Free Cash Flow
NFE
NFE
PTCT
PTCT
Q4 25
$-134.8M
$-36.6M
Q3 25
$-231.6M
$-69.7M
Q2 25
$-726.7M
$-59.6M
Q1 25
$-262.3M
$868.4M
Q4 24
$-210.3M
$-33.8M
Q3 24
$-367.0M
$-77.5M
Q2 24
$-493.2M
$-78.8M
Q1 24
$-457.9M
$61.2M
FCF Margin
NFE
NFE
PTCT
PTCT
Q4 25
-41.3%
-22.3%
Q3 25
-96.4%
-33.1%
Q2 25
-318.6%
-33.3%
Q1 25
-68.2%
73.8%
Q4 24
-60.0%
-15.8%
Q3 24
-82.3%
-39.4%
Q2 24
-169.3%
-42.2%
Q1 24
-75.1%
29.1%
Capex Intensity
NFE
NFE
PTCT
PTCT
Q4 25
18.0%
1.4%
Q3 25
25.2%
1.6%
Q2 25
174.4%
0.7%
Q1 25
66.3%
0.1%
Q4 24
187.0%
1.8%
Q3 24
77.8%
0.3%
Q2 24
208.4%
4.0%
Q1 24
85.5%
4.6%
Cash Conversion
NFE
NFE
PTCT
PTCT
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
-2.15×
Q2 24
Q1 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons